<html>
<head><meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<title>Appendix F Radiation Glossary</title>
</head><body bgcolor=#FFFFFF text=#000000 link=#0000ff vlink=#006666>

<center>
  <table border=0 width=600>
    <tr> 
      <td valign="top"> 
        <center>
          <p><font size=4 face=arial>APPENDIX F<br>
            Radiation Glossary<br>
            <br>
            </font><hr></p>
        </center>
        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">These selected 
          definitions are provided by the State of Kentucky's Radioactive Material 
          Regulations, 902 KAR 100:010, Section 1. The complete section of regulations 
          is available at the Radiation Safety Office.</font></p>
        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&quot;Annual 
          limit on intake (ALI)&quot;</b> means the derived limit for the amount 
          of radioactive material taken into the body of an adult worker by inhalation 
          or ingestion in a year. ALI is the smaller value of intake of a given 
          radionuclide in a year by the reference man that would result in a committed 
          effective dose equivalent of five (5) rems (0.05 Sv) or a committed 
          dose equivalent of fifty (50) rems (five-tenths (0.5) Sv) to an individual 
          organ or tissue. (ALI values for intake by ingestion and by inhalation 
          of selected radionuclides are given in 902 KAR 100:019, Section 44, 
          Table 1, Columns 1 and 2.)</font></p>
        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&quot;As 
          low as reasonably achievable (ALARA)&quot;</b> means making every reasonable 
          effort to maintain exposures to radiation as far below the dose limits 
          in 902 KAR 100:019 as practical, consistent with the purpose for which 
          the licensed activity is undertaken. ALARA shall take into account the 
          state of technology, the economics of improvement in relation to benefits 
          to the public health and safety, and other societal and socio-economic 
          considerations, in relation to the utilization of nuclear energy and 
          radioactive materials in the public interest.</font></p>
        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&quot;Curie&quot;</b> 
          means a quantity of radioactivity. One (1) curie (Ci) is that quantity 
          of radioactive material which decays at the rate of 3.7 x 1010 disintegrations 
          per second (dps). Commonly used submultiples of the curie are the millicurie 
          and the microcurie. One (1) millicurie (mCi) = 0.001 curie = 3.7 x 107 
          dps. One (1) microcurie (uCi) = 0.000001 curie = 3.7 x 104 dps.</font></p>
        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&quot;Exposure&quot;</b> 
          means being exposed to ionizing radiation or to radioactive material.</font></p>
        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&quot;Extremity&quot;</b> 
          means hand, elbow, arm below the elbow, foot, knee, or leg below the 
          knee.</font></p>
        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&quot;High 
          radiation area&quot;</b> means an area, accessible to individuals, in 
          which radiation levels may result in an individual receiving a dose 
          equivalent in excess of one-tenth (0.1) rem (1 mSv) in one (1) hour 
          at thirty (30) centimeters from the radiation source or from a surface 
          that the radiation penetrates.</font></p>
        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&quot;Human 
          use&quot;</b> means the internal or external administration of radiation 
          or radioactive materials to human beings.</font></p>
        <p></p>
        <p><b><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&quot;Misadministration&quot;</font></b><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> 
          means the administration of:</font></p>
        <ul>
          <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> A radiopharmaceutical 
            dosage greater than thirty (30) microcuries of sodium iodide I-125 
            or I-131:</font> 
            <ul>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Involving 
                the wrong patient or wrong radiopharmaceutical; or route of administration; 
                or</font></li>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> 
                If both the administered dosage differs from the prescribed dosage 
                by more than twenty (20) percent of the prescribed dosage and 
                the difference between the administered dosage and prescribed 
                dosage exceeds thirty (30) microcuries.</font></li>
            </ul>
          </li>
          <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> A therapeutic 
            radiopharmaceutical dosage, other than sodium iodide I-125 or I-131:</font> 
            <ul>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> 
                Involving the wrong patient, radiopharmaceutical, or route of 
                administration; or</font></li>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> 
                If the administered dosage differs from the prescribed dosage 
                by more than twenty (20) percent of the prescribed dosage.</font></li>
            </ul>
          </li>
          <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> A gamma 
            stereotactic radiosurgery radiation dose:</font> 
            <ul>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> 
                Involving the wrong patient or treatment site; or</font></li>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> 
                If the calculated total administered dose differs from the total 
                prescribed dose by more than ten (10) percent of the total prescribed 
                dose.</font></li>
            </ul>
          </li>
          <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> A teletherapy 
            radiation dose:</font> 
            <ul>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> 
                Involving the wrong patient, mode of treatment, or treatment site;</font></li>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> 
                If the treatment consists of three (3) or fewer fractions and 
                the calculated total administered dose differs from the total 
                prescribed dose by more than ten (10) percent of the total prescribed 
                dose;</font></li>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> 
                If the calculated weekly administered dose is thirty (30) percent 
                greater than the weekly prescribed dose; or</font></li>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> 
                If the calculated total administered dose differs from the total 
                prescribed dose by more than twenty (20) percent of the prescribed 
                dose.</font></li>
            </ul>
          </li>
          <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> A brachytherapy 
            radiation dose:</font> 
            <ul>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> 
                Involving the wrong patient, radioisotope, or treatment site (excluding 
                permanent implant seeds that were implanted in the correct site 
                but migrated outside the treatment site);</font></li>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> 
                Involving a sealed source that is leaking;</font></li>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> 
                If, for a temporary implant, one (1) or more sealed sources are 
                not removed upon completion of the procedure; or</font></li>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> 
                If the calculated administered dose differs from the prescribed 
                dose by more than twenty (20) percent of the prescribed dose.</font></li>
            </ul>
          </li>
          <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> A diagnostic 
            radiopharmaceutical dosage, other than quantities greater than thirty 
            (30) microcuries of sodium iodide I-125 or I-131:</font> 
            <ul>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> 
                Involving the wrong patient, radiopharmaceutical, route of administration, 
                or if the administered dosage differs from the prescribed dosage; 
                and</font></li>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> 
                If the dose to the patient exceeds five (5) rems effective dose 
                equivalent or fifty (50) rems dose equivalent to an individual 
                organ.</font></li>
            </ul>
          </li>
        </ul>
        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&quot;Rad&quot;</b> 
          means the special unit of absorbed dose. One (1) rad equals an absorbed 
          dose of 0.01 joule per kilogram (0.01 gray) or 100 ergs per gram.</font></p>
        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&quot;Radiation 
          area&quot;</b> means an area, accessible to individuals, in which there 
          exists radiation at levels that an individual may receive in excess 
          of five (5) millirems (0.05 mSv) in one (1) hour at thirty (30) centimeters 
          from the radiation source or from a surface that the radiation penetrates.</font></p>
        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&quot;Recordable 
          event&quot;</b> means the administration of:</font></p>
        <ul>
          <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> A radiopharmaceutical 
            or radiation without a written directive if a written directive is 
            required;</font></li>
          <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> A radiopharmaceutical 
            or radiation if a written directive is required without daily recording 
            of each administered radiopharmaceutical dosage or radiation dose 
            in the appropriate record;</font></li>
          <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> A radiopharmaceutical 
            dosage greater than thirty (30) microcuries of sodium iodide I-125 
            or I-131 if:</font>
            <ul>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> 
                The administered dosage differs from the prescribed dosage by 
                more than ten (10) percent of the prescribed dosage, and</font></li>
              <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The 
                difference between the administered dosage and prescribed dosage 
                exceeds fifteen (15) microcuries;</font></li>
            </ul>
          </li>
          <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> A therapeutic 
            radiopharmaceutical dosage, other than sodium iodide I-125 or I-131, 
            if the administered dosage differs from the prescribed dosage by more 
            than ten (10) percent of the prescribed dosage;</font></li>
          <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> A teletherapy 
            radiation dose if the calculated weekly administered dose is fifteen 
            (15) percent greater than the weekly prescribed dose; or</font></li>
          <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> A brachytherapy 
            radiation dose if the calculated administered dose differs from the 
            prescribed dose by more than ten (10) percent of the prescribed dose.</font></li>
        </ul>
        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&quot;Rem&quot;</b> 
          means a special unit of quantities expressed as dose equivalent. The 
          dose equivalent in rems is equal to the absorbed dose in rads multiplied 
          by the quality factor (one (1) rem = 0.01 sievert).</font></p>
        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&quot;Restricted 
          area&quot;</b> means an area access to which is limited by the licensee 
          or registrant for purposes of protection of individuals against undue 
          risks from exposure to radiation and radioactive materials. A restricted 
          area shall not include areas used as residential quarters, although 
          a separate room or rooms in a residential building may be set apart 
          as a restricted area.</font></p>
        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&quot;Roentgen&quot;</b> 
          means the special unit of exposure. One (1) roentgen &reg; equals 2.58 
          x 10-4 coulombs per kilogram of air (see &quot;Exposure&quot;).</font></p>
        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&quot;Sealed 
          Source&quot;</b> means radioactive material that is permanently bonded 
          or fixed in a capsule or matrix designed to prevent leakage or escape 
          of the radioactive material.</font><font size=2 face=arial> </font></p>
        <font size=2 face=arial> 
        <p> <hr> 
        </font> 
        <p> 
        <center>
          <p><font size="2" face="arial"><b><a href="newradman.html">Radiation 
            Safety Manual</a> | <a href="newappe.html">Appendix E</a></b></font></p>
          <div align="left"> 
            <p><font face="Verdana, Arial, Helvetica, sans-serif" size="1">Webmaster 
              <a href="mailto:dvcask2@email.uky.edu"> J. King</a><br>
              7-23-2002</font></p>
          </div>
        </center>
      </td>
    </tr></table>
</center><script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-40196994-1', 'uky.edu');
  ga('send', 'pageview');

</script>
</body>
</html>
